ALTIFLEX Trademark

Trademark Overview

On Thursday, March 31, 2022, a trademark application was filed for ALTIFLEX with the United States Patent and Trademark Office. The USPTO has given the ALTIFLEX trademark a serial number of 97340287. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, August 28, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The ALTIFLEX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Genetic engineering services, namely, the production of genetically-engineered antibodies for others
altiflex

General Information

Serial Number97340287
Word MarkALTIFLEX
Filing DateThursday, March 31, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, August 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements

Goods and ServicesGenetic engineering services, namely, the production of genetically-engineered antibodies for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 5, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, April 4, 2022NEW APPLICATION ENTERED
Tuesday, April 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 19, 2022ASSIGNED TO EXAMINER
Wednesday, December 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 23, 2023SOU EXTENSION 1 FILED
Wednesday, August 23, 2023SOU EXTENSION 1 GRANTED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 19, 2024SOU EXTENSION 2 GRANTED
Tuesday, March 19, 2024SOU EXTENSION 2 FILED
Tuesday, March 19, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 28, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 28, 2024SOU EXTENSION 3 GRANTED
Wednesday, August 28, 2024SOU EXTENSION 3 FILED

Related Keywords

altiflex engineered antibodies others genetically production engineering services namely genetic